Sven Sievers

Sven Sievers has a long and varied career in the healthcare industry. Sven began in 1988 as a Product Manager for the Nordic Region at Viggo-Spectramed. In 1990, they moved to the Swedish Trade Council/Exportrådet as a Market Consultant for Health Care. From 1993 to 2000, they worked at Astra in various roles, including Strategic Planning Director and International Product Manager. In 2000, they became a Director of Business Analysis at AstraZeneca. In 2008, they moved to ArthroCare Corp. as a Global Product Marketing Manager. In 2010, they became a Partner at Zelibra Life Science. From 2013 to 2019, they worked at Business Sweden as a Global Business Developer for SMEs. In 2019, they became the Chairman of Stiftelsen Emyhemmet. Since 2020, they have been a Senior Consultant at Calyba AB and a Commercial Manager at Gesynta Pharma AB.

Sven Sievers began their educational journey at Teknikum, where they obtained a Diploma in Chemical Engineering in 1982. Sven then attended Lund University from 1983 to 1987, studying Business Administration and Modern Languages. In 1992, they enrolled in Uppsala University, where they studied Political Science for one year. In 2005, they completed a Professional Postgraduate Diploma in Marketing at CIM | The Chartered Institute of Marketing. In 2011, they studied Medical Genetics at Karolinska Institutet. In 2017, they earned their Certifierad Styrelseledamot - Certified Board Member from Styrelseakademien - The Swedish Academy of Board Directors. Finally, in 2019, they completed an IP Pre-diagnostic training in Intellectual Property Management at EUIPO.